Labe James purchased $1.5M of TPVG (indirect holdings)

Labe James (Chief Executive Officer) purchased 313,865 indirectly-held shares of TriplePoint Venture Growth BDC Corp. (TPVG) at $4.71 ($1.48M total) on 2026-09-18.

Original reporting
SEC EDGAR · Labe James
Published Sep 22, 2026, 8:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 8:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TPVG
Bullish
medium confidence
Mentioned
$TPVG
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TPVGBullishMed
01

Why it matters

The purchase adds to insider confidence perception, potentially influencing short-term trading decisions.

02

Market read

First report of a $1.5M insider purchase; modest but material for traders tracking insider activity.

03

What to watch

No disclosed 10b5-1 plan; purchase may be opportunistic rather than strategic.

Relevance 7/10Novelty 7/10Timing: post-market filing on 2026-09-22

Background

Form 4 filing reports insider transactions; provides first public disclosure of the trade.

Company-level read

Ticker impact

$TPVGBullishMedium confidence
Context

CEO Labe James bought 313,865 shares for $1.48M, increasing his stake to 2.31M shares.

Expected impact

Potential modest price lift in the near term.

Evidence & confidence

CEO acquisition of $1.5M worth of stock is a material insider buy, suggesting bullish outlook.

Market effects

May reinforce positive sentiment for BDC sector.

Limited to US market where TPVG trades.

Low global impact.

Counterpoint

Insider buy could be a routine portfolio rebalancing, not a strong signal.

Key entities

  • Labe James

    Chief Executive Officer of TriplePoint Venture Growth BDC Corp.

  • TriplePoint Venture Growth BDC Corp.

    US-listed business development company (ticker TPVG).

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TPVGMed

TriplePoint Venture Growth BDC Corp (TPVG) (Q3 2026) Earnings Call Highlights: NAV Slips

TriplePoint Venture Growth BDC Corp (TPVG) reported Q3 2026 earnings with a net asset value decline to $8.32 per share. The company signed $106M in term sheets and closed $43M in debt commitments, up 45% from Q2. Despite strong demand, net investment income fell to $6.6M, and dividend coverage remains a concern. TPVG has $168M in liquidity and reduced leverage to 1.18x. Management extended the income incentive fee waiver through 2027 and is evaluating dividend policy.

$TPVGMed

TriplePoint Venture Growth BDC Corp. Announces Third Quarter 2026 Financial Results

TriplePoint Venture Growth BDC Corp. (TPVG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 TriplePoint Venture Growth BDC Corp. Announces Third Quarter 2026 Financial Results Declared Fourth Quarter 2026 Regular Distribution of $0.23 per Share Seven Portfolio Companies Raised an Aggregate $2.6 Billion of Capital Menlo Park, Calif., November 4, 2026 - Tripl

$TPVGMed

TriplePoint Venture Growth BDC Q2 Earnings Call Highlights

TriplePoint Venture Growth BDC (TPVG) reported Q2 results on an earnings call. It received $28.6M in loan prepayments and sold Prodigy Investments debt and equity for $43.8M. Total investment income was $22.1M, net investment income $8.3M ($0.21/share). NAV rose to $8.67. Board declared a $0.12 supplemental distribution.

$TPVGMed

TriplePoint Venture Growth BDC Corp. Announces Second Quarter 2026 Financial Results

TriplePoint Venture Growth BDC Corp. (TPVG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 TriplePoint Venture Growth BDC Corp. Announces Second Quarter 2026 Financial Results Net Increase in Net Assets Resulting from Operations of $0.26 per Share for the Second Quarter Declares Third Quarter 2026 Regular Distribution of $0.23 per Share and Supplemental Di

$MDGLMedAI 8/10

BAKER BROS. ADVISORS LP (BAKER FELIX, BAKER JULIAN) purchased $35.0M of MDGL (indirect holdings)

BAKER BROS. ADVISORS LP purchased 91,806 indirectly-held shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) at an average of $381.49 ($366.99–$396.61, $35.02M total) across 5 trades over 2026-11-04 to 2026-11-06. Filed jointly with Baker Bros. Advisors (GP) LLC (Director), BAKER FELIX (Director), BAKER JULIAN (Director), 667, L.P. (Director) and Baker Brothers Life Sciences LP (Director).